Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2015 (2015), Article ID 586827, 6 pages
Clinical Study

Quality of Life and Volume Reduction in Women with Secondary Lymphoedema Related to Breast Cancer

1Centro Universitário Augusto Motta, Rio de Janeiro, Brazil
2Instituto Nacional de Câncer, Rio de Janeiro, Brazil
3Centro Vodder Argentina, Buenos Aires, Argentina
4Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

Received 17 July 2015; Accepted 24 November 2015

Academic Editor: Debra A. Tonetti

Copyright © 2015 Marcus Lanza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Purpose. To assess the quality of life (QOL) as a predictor of volume reduction in women undergoing complex physical therapy (CPT) for lymphoedema following breast cancer. Methods. Clinical trial in 57 women undergoing CPT. Results. At baseline, in measuring quality of life for the EORTC QLQ-C30 questionnaire subscale of functionality, the worst scores for emotional function (55 points) and better social function (89 points) were observed. The symptom scales showed the worst pain averaged (66 points). The overall quality of life showed a low score (40 points). In the BR 23 module, low scores were observed in the field of future perspective (47 points). After treatment of lymphoedema, absolute reduction of excess volume between the upper limbs of 282 mL was observed, representing a reduction of 15%. No association was observed between the domains of quality of life and response to treatment of lymphoedema. Conclusion. This study included 57 women with advanced and chronic lymphoedema in early treatment with CPT and low scores for quality of life. The lymphoedema therapeutic response was not influenced by the QOL at the beginning of treatment.